Skip to content

E-Stim: Neuromuscular electric stimulation to treat sarcopenia in patients at intensive or intermediate care unit

E-Stim: Neuromuscular electric stimulation to treat sarcopenia in patients at intensive or intermediate care unit - E-Stim

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025106
Enrollment
30
Registered
2021-04-20
Start date
2021-03-27
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Group 1: Intervention Group Patients are treated - next to the regular physical therapy - with a daily one hour electric stimulation of the legs for at least 2 weeks, maximum 6 weeks. Group 2: Contr

Sponsors

Innere Medizin III Universtitätklinikum Heidelberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - stay of at least 2 weeks at intensive care unit - written consent

Exclusion criteria

Exclusion criteria: - cardiogenic shock - extracorporeal membrane oxygenation, impella - myocardial infarction (STEMI) within the last 7 days - RR II - abnormality of the skin within the area of Stimulation - psychiatric diseases, Delirium - pregnancy - metallic implants of the legs - progressive and fast course of a disease, which doesn't allow to see the effect of the treatment

Design outcomes

Primary

MeasureTime frame
Improvement of the STIMFIT5-Score in comparison to the control group. The Score depends on: - 6-minute-walking test - repetitions in Sit-to-Stand-Test (30 sec.) - repetitions in going to tiptoe (30 sec.) - repetitions in extending the knee in a supine position - repetitions in lifting the leg in a supine position

Secondary

MeasureTime frame
- muscle thickness and cross sectional area of musculus vastus lateralis measured by ultrasound - Quality of life (PHQ9) - study dropouts due to adverse events

Countries

Germany

Contacts

Public ContactTheresa Betz

Innere Medizin III

theresamaria.betz@med.uni-heidelberg.de06221-5632896

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026